Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFPChoosing and Responding to Government Bids
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Research and Development concerning both Bacterial and…

U.S. Department Of Defense·Virginia

Research and Development concerning both Bacterial and Viral Infections

Closes 5/19/2026$500k – $2MRequest for Proposal
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The U.S. Naval Medical Research Unit (NAMRU) INDO PACIFIC is seeking research and development services to improve standardized laboratory procedures for detecting biothreat agents, arboviruses, and antibiotic-resistant organisms. The contractor will be responsible for developing detailed consensus genomes for regional pathogens of concern and providing a bioinformatic platform to identify novel emerging and re-emerging infectious diseases. The contractor will also provide on-site training to laboratory staff at NAMRU INDO PACIFIC's collaborating sites and complete next-generation sequencing of at least 100 samples. Some key aspects of the job include: * Improving laboratory procedures for detecting biothreat agents and antibiotic-resistant organisms * Developing consensus genomes for regional pathogens of concern * Providing a bioinformatic platform for identifying novel emerging and re-emerging infectious diseases * Providing on-site training to laboratory staff at collaborating sites * Completing next-generation sequencing of at least 100 samples

Attached files

Contact

Brian Kinkade

[email protected]

(771) 229-2412

Key dates

Opened
5/13/2026
Closes
5/19/2026

Last updated

Details

Type
Request for Proposal
Industry
Healthcare and Medical Services
NAICS
541715
Solicitation №
N0018926BUMED

Budget estimate

$500,000 – $2,000,000

The budget for this opportunity is not explicitly stated in the document. However, based on the scope of work, which includes research and development services, on-site training, and next-generation sequencing, it is likely that the budget will be in the range of $500,000 to $2 million. This estimate is based on the assumption that the contractor will need to invest in personnel, equipment, and travel to complete the tasks outlined in the opportunity. Factors that may influence the likely payment range include the complexity of the research and development tasks, the number of samples to be sequenced, and the level of training required for laboratory staff.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 71%

Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases

Closes 1/21/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

70% match

Partnerships for Advancing Development of Diagnostics for Infectious Diseases

Closes 10/13/2027Opened 9/24/2026

U.S. Department Of Energy·Ohio

70% match

TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform

Closes 12/15/2026Opened 6/15/2026

U.S. National Institutes of Health·United States of America

68% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

68% match

Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)

Closes 1/25/2028Opened 6/17/2025

U.S. National Institutes of Health·United States of America

68% match

NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)

Closes 5/25/2029Opened 6/16/2025

U.S. National Institutes of Health·United States of America

68% match

Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)

Closes 11/10/2026Opened 3/10/2026

U.S. National Institutes of Health·United States of America

68% match

Centers for Research on Neglected Infectious Diseases

Closes 6/14/2027Opened 10/6/2026

U.S. Centers for Disease Control - NCHHSTP·United States of America

68% match

National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers

Closes 6/30/2027Opened 7/9/2026

U.S. National Institutes of Health·United States of America

68% match

Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 5/28/2027Opened 12/22/2025

U.S. National Institutes of Health·United States of America

68% match

Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)

Closes 9/28/2028Opened 6/9/2025

U.S. Centers for Disease Control - NCHHSTP·United States of America

67% match

Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use

Closes 6/22/2027Opened 7/24/2026

U.S. National Institutes of Health·United States of America

67% match

Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 5/20/2026

U.S. Food and Drug Administration·United States of America

67% match

Vet-LIRN Capacity-Building Project and Equipment Grants (U18)

Closes 9/4/2028Opened 5/18/2023

U.S. Department Of Health And Human Services·United States of America

67% match

2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases

Closes 12/8/2026Opened 10/9/2026

U.S. National Institutes of Health·United States of America

67% match

Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 4/9/2026

U.S. National Institutes of Health·United States of America

67% match

Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 1/8/2025

U.S. Food and Drug Administration·United States of America

67% match

Animal and Veterinary Innovation Centers (U18)

Closes 5/12/2028Opened 6/20/2024

U.S. National Science Foundation·United States of America

66% match

A Science of Science Approach to Analyzing and Innovating the Biomedical Research Enterprise (SoS:BIO)

Closes 2/9/2027Opened 3/21/2023

U.S. National Institutes of Health·United States of America

66% match

Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)

Closes 1/9/2029Opened 6/9/2025

U.S. National Institutes of Health·United States of America

66% match

Technology Development Program

Closes 2/4/2028Opened 9/16/2026

U.S. Department Of Veterans Affairs·Florida

66% match

6632--FY27 Microbial Incubation ID and Susceptibility CPT

Closes 11/10/2026Opened 10/27/2026

U.S. Centers for Disease Control and Prevention - ERA·United States of America

66% match

Expanded Surveillance for Pediatric Infectious Diseases

Closes 1/29/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

66% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. Food and Drug Administration·United States of America

66% match

NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens

Rolling / TBD closeOpened 11/5/2024